Repligen Corporation RGEN
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 209.31M | 204.13M | 194.26M | 197.91M | 188.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 209.31M | 204.13M | 194.26M | 197.91M | 188.81M |
| Cost of Revenue | 98.33M | 94.09M | 85.97M | 94.08M | 88.29M |
| Gross Profit | 110.99M | 110.04M | 108.28M | 103.83M | 100.52M |
| SG&A Expenses | 83.59M | 76.62M | 76.54M | 74.36M | 73.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 196.36M | 185.13M | 176.97M | 181.57M | 176.13M |
| Operating Income | 12.96M | 19.00M | 17.29M | 16.35M | 12.68M |
| Income Before Tax | -26.81M | 14.15M | 1.77M | 19.11M | 17.11M |
| Income Tax Expenses | 11.62M | 9.15M | -6.56M | 5.83M | 2.20M |
| Earnings from Continuing Operations | -38.43M | 5.01M | 8.33M | 13.29M | 14.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.43M | 5.01M | 8.33M | 13.29M | 14.91M |
| EBIT | 12.96M | 19.00M | 17.29M | 16.35M | 12.68M |
| EBITDA | 32.08M | 38.06M | 37.05M | 36.30M | 32.69M |
| EPS Basic | -0.68 | 0.09 | 0.15 | 0.24 | 0.27 |
| Normalized Basic EPS | 0.17 | 0.21 | 0.19 | 0.20 | 0.14 |
| EPS Diluted | -0.68 | 0.09 | 0.15 | 0.23 | 0.26 |
| Normalized Diluted EPS | 0.17 | 0.21 | 0.19 | 0.19 | 0.14 |
| Average Basic Shares Outstanding | 56.56M | 56.42M | 56.35M | 56.31M | 56.27M |
| Average Diluted Shares Outstanding | 56.56M | 56.64M | 56.67M | 56.66M | 56.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |